Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bally's (BALY) Liabilities and Shareholders Equity (2018 - 2025)

Bally's (BALY) has disclosed Liabilities and Shareholders Equity for 8 consecutive years, with $7.6 billion as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 17.94% to $7.6 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $21.2 billion, a 19.94% decrease, with the full-year FY2024 number at $5.9 billion, down 14.59% from a year prior.
  • Liabilities and Shareholders Equity was $7.6 billion for Q3 2025 at Bally's, down from $7.8 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $7.8 billion in Q2 2025 to a low of $2.1 billion in Q1 2021.
  • A 5-year average of $6.0 billion and a median of $6.4 billion in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 295.4% in 2021, then decreased 14.59% in 2024.
  • Bally's' Liabilities and Shareholders Equity stood at $6.6 billion in 2021, then dropped by 3.86% to $6.3 billion in 2022, then rose by 8.9% to $6.9 billion in 2023, then fell by 14.59% to $5.9 billion in 2024, then grew by 28.92% to $7.6 billion in 2025.
  • Per Business Quant, the three most recent readings for BALY's Liabilities and Shareholders Equity are $7.6 billion (Q3 2025), $7.8 billion (Q2 2025), and $5.9 billion (Q4 2024).